Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients.

OBJECT Intrathecal baclofen therapy is an effective means of treating intractable spasticity and dystonia in the pediatric and adult population. The authors present a review of complications encountered in a series of 314 pump and catheter-related procedures. The identification and management of these complications will be reviewed. The authors will also identify populations that may be at increased risk for complications. METHODS A retrospective review was performed of all procedures undertaken during the last 5 years by two surgeons at the authors' institution. Postoperative complications were reviewed. A total of 314 surgical procedures (226 pediatric and 88 adult) were performed in 195 pediatric and adult patients. This included 171 new pump and catheter implants (116 pediatric and 55 adult), 26 elective pump replacements due to end of battery life (15 pediatric and 11 adult), five elective pump repositionings per physiatrist request (three pediatric and two adult), 14 elective catheter repositionings (10 pediatric and four adult), and two normal pediatric catheter explorations. Surgical procedures for complication management included seven pump revisions (five pediatric and two adult), 48 catheter revisions (38 pediatric and 10 adult), and 41 wound revisions (37 pediatric and four adult). The majority of adult pumps were implanted subdermally, whereas in pediatric patients they were placed subfascially. In general, intrathecal catheters were placed under fluoroscopic guidance with the catheter tip placed at T-1 to T-2 for spastic quadriplegia, T-6 to T-10 for spastic diplegia, and midcervical for dystonia. No significant intraoperative complications were encountered. Overall, there was a statistically significantly higher percentage of procedures for overall complication management and wound complication management in pediatric patients compared with adult patients. CONCLUSIONS Intrathecal baclofen therapy is a highly effective treatment option for patients with medically refractory spasticity. The catheter, pump, and wound are subject to numerous complications both at the time of implantation and throughout the life of the implanted system. Careful technique, close observation, and aggressive evaluation and correction of problems can reduce the incidence and severity of the complications when they occur.

[1]  P. Menei,et al.  Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients , 2004, Spinal Cord.

[2]  J. Drake,et al.  Prevention and Management of Intrathecal Drug Delivery and Spinal Cord Stimulation System Infections , 2004, Anesthesiology.

[3]  S. Korfias,et al.  Infected CNS infusion pumps. Is there a chance for treatment without removal? , 2004, Acta Neurochirurgica.

[4]  M. Walker,et al.  Complications of Intrathecal Baclofen Pumps in Children , 2003, Pediatric Neurosurgery.

[5]  L. Krach,et al.  Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. , 2003, Journal of neurosurgery.

[6]  S. Schneider,et al.  The Role of Surgical Placement and Pump Orientation in Intrathecal Pump System Failure: A Technical Report , 2003, Pediatric Neurosurgery.

[7]  H. Weiner,et al.  Subfascial Implantation of Intrathecal Baclofen Pumps in Children: Technical Note , 2001, Neurosurgery.

[8]  K. Follett,et al.  A prospective study of catheter-related complications of intrathecal drug delivery systems. , 2000, Journal of pain and symptom management.

[9]  H. Stiver,et al.  Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis. Case report. , 2000, Journal of neurosurgery.

[10]  B. Rawicki,et al.  Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients. , 1999, Journal of neurosurgery.

[11]  J. Meythaler,et al.  Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. , 1999, Neurosurgery.

[12]  M. Hadley,et al.  Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. , 1997, Journal of neurosurgery.

[13]  R. Rauck,et al.  Meningitis after injection of intrathecal baclofen. , 1996, Anesthesia and analgesia.

[14]  R. Penn,et al.  Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. , 1993, Journal of neurosurgery.

[15]  R. Penn Intrathecal baclofen for spasticity of spinal origin: seven years of experience. , 1992, Journal of neurosurgery.

[16]  G. Tomei,et al.  A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity , 2004, Drug safety.

[17]  M. Painter,et al.  Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. , 1998, Journal of neurosurgery.